84 related articles for article (PubMed ID: 15761067)
1. Emergence of Staphylococcus hominis strains expressing low-level resistance to quinupristin/dalfopristin in Greece.
Petinaki E; Spiliopoulou I; Maniati M; Maniatis AN
J Antimicrob Chemother; 2005 May; 55(5):811-2. PubMed ID: 15761067
[No Abstract] [Full Text] [Related]
2. Emergence of Enterococcus faecalis susceptible to quinupristin/dalfopristin in Greece.
Petinaki E; Kontos F; Maniatis AN; Spiliopoulou I; Liakos P
Int J Antimicrob Agents; 2006 Aug; 28(2):153-6. PubMed ID: 16854572
[No Abstract] [Full Text] [Related]
3. Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.
Mendoza-Olazarán S; Morfín-Otero R; Villarreal-Treviño L; Rodríguez-Noriega E; Llaca-Díaz J; Camacho-Ortiz A; González GM; Casillas-Vega N; Garza-González E
PLoS One; 2015; 10(12):e0144684. PubMed ID: 26659110
[TBL] [Abstract][Full Text] [Related]
4. Identification of Staphylococcus species with the VITEK 2 system: the case of Staphylococcus hominis.
Gilad J; Schwartz D
J Clin Microbiol; 2007 Feb; 45(2):685; author reply 685-6. PubMed ID: 17277175
[No Abstract] [Full Text] [Related]
5. Staphylococcus hominis subsp. novobiosepticus strains causing nosocomial bloodstream infection in Brazil.
Palazzo IC; d'Azevedo PA; Secchi C; Pignatari AC; Darini AL
J Antimicrob Chemother; 2008 Dec; 62(6):1222-6. PubMed ID: 18775890
[TBL] [Abstract][Full Text] [Related]
6. Microbiological and molecular characterization of Staphylococcus hominis isolates from blood.
Mendoza-Olazarán S; Morfin-Otero R; Rodríguez-Noriega E; Llaca-Díaz J; Flores-Treviño S; González-González GM; Villarreal-Treviño L; Garza-González E
PLoS One; 2013; 8(4):e61161. PubMed ID: 23585877
[TBL] [Abstract][Full Text] [Related]
7. Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit.
Sorlozano A; Gutierrez J; Martinez T; Yuste ME; Perez-Lopez JA; Vindel A; Guillen J; Boquete T
Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):73-80. PubMed ID: 19876662
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and molecular analysis of Enterococcus faecalis originating from endodontic infections in Finland and Lithuania.
Reynaud Af Geijersstam AH; Ellington MJ; Warner M; Woodford N; Haapasalo M
Oral Microbiol Immunol; 2006 Jun; 21(3):164-8. PubMed ID: 16626373
[TBL] [Abstract][Full Text] [Related]
9. Linezolid-resistant Staphylococcus haemolyticus and Staphylococcus hominis: single and double mutations at the domain V of 23S rRNA among isolates from a Rio de Janeiro hospital.
Chamon RC; Iorio NL; Cavalcante FS; Teodoro CR; de Oliveira AP; Maia F; dos Santos KR
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):307-10. PubMed ID: 25294302
[TBL] [Abstract][Full Text] [Related]
10. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.
de Almeida LM; de Araújo MR; Sacramento AG; Pavez M; de Souza AG; Rodrigues F; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM
Antimicrob Agents Chemother; 2013 Aug; 57(8):4082-3. PubMed ID: 23689714
[No Abstract] [Full Text] [Related]
11. Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens.
Szczuka E; Makowska N; Bosacka K; Słotwińska A; Kaznowski A
Folia Microbiol (Praha); 2016 Mar; 61(2):143-7. PubMed ID: 26253583
[TBL] [Abstract][Full Text] [Related]
12. DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy.
Bongiorno D; Campanile F; Mongelli G; Baldi MT; Provenzani R; Reali S; Lo Russo C; Santagati M; Stefani S
J Antimicrob Chemother; 2010 Nov; 65(11):2336-40. PubMed ID: 20852270
[TBL] [Abstract][Full Text] [Related]
13. Genotypic Diversity of Methicillin-Resistant Coagulase-Negative Staphylococci Isolated from Inpatients and Outpatients.
Talebi M; Shafiee M; Sadeghi J; Moghadam NA; Saifi M; Pourshafie MR
Microb Drug Resist; 2016 Mar; 22(2):147-54. PubMed ID: 26248114
[TBL] [Abstract][Full Text] [Related]
14. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
15. Detection of quinupristin-dalfopristin resistance in methicillin-resistant Staphylococcus aureus in South India.
Kali A; Stephen S; Umadevi S; Kumar S
Indian J Pathol Microbiol; 2013; 56(1):73-4. PubMed ID: 23924572
[No Abstract] [Full Text] [Related]
16. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
Karanika M; Prati A; Kiritsi M; Spiliopoulou I; Neonakis I; Anifantaki M; Petinaki E
Int J Antimicrob Agents; 2008 Jan; 31(1):55-7. PubMed ID: 17923393
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin.
Schmitz FJ; Sadurski R; Stattfeld A; Kray A; Verhoef J; Fluit AC
J Antimicrob Chemother; 1999 Dec; 44(6):847-9. PubMed ID: 10590291
[No Abstract] [Full Text] [Related]
19. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
